Streamline Health Solutions, Inc. (STRM): Price and Financial Metrics
GET POWR RATINGS... FREE!
STRM Stock Summary
- With a market capitalization of $97,607,832, STREAMLINE HEALTH SOLUTIONS INC has a greater market value than only 20.64% of US stocks.
- STRM's price/sales ratio is 4.04; that's higher than the P/S ratio of 74.45% of US stocks.
- Revenue growth over the past 12 months for STREAMLINE HEALTH SOLUTIONS INC comes in at 69.08%, a number that bests 89.15% of the US stocks we're tracking.
- If you're looking for stocks that are quantitatively similar to STREAMLINE HEALTH SOLUTIONS INC, a group of peers worth examining would be RNLX, VORB, LVOX, SSYS, and CTSO.
- STRM's SEC filings can be seen here. And to visit STREAMLINE HEALTH SOLUTIONS INC's official web site, go to www.streamlinehealth.net.
STRM Valuation Summary
- STRM's price/sales ratio is 4; this is 60% higher than that of the median Technology stock.
- STRM's price/sales ratio has moved up 2.3 over the prior 243 months.
Below are key valuation metrics over time for STRM.
STRM Growth Metrics
- Its year over year cash and equivalents growth rate is now at -52.44%.
- Its 3 year cash and equivalents growth rate is now at 295.97%.
- The 4 year net cashflow from operations growth rate now stands at -234.37%.
The table below shows STRM's growth in key financial areas (numbers in millions of US dollars).
|Date||Revenue||Operating Cash Flow||Net Income to Common Stock|
STRM Price Target
For more insight on analysts targets of STRM, see our STRM price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
|Average Price Target||$2.75||Average Broker Recommendation||1.5 (Moderate Buy)|
STRM Stock Price Chart Interactive Chart >
STRM Price/Volume Stats
|Current price||$1.80||52-week high||$2.35|
|Prev. close||$1.78||52-week low||$1.04|
|Day high||$1.85||Avg. volume||68,215|
|50-day MA||$1.94||Dividend yield||N/A|
|200-day MA||$1.64||Market Cap||103.35M|
Streamline Health Solutions, Inc. (STRM) Company Bio
Streamline Health Solutions, Inc. provides health information technology solutions and associated services for hospitals and health systems in the United States and Canada. It provides computer software-based solutions and auditing services, which captures, aggregates, and translates structured and unstructured data to deliver predictive insights. The company also offers health information management; coding and clinical documentation improvement (CDI) solutions, which includes integrated cloud-based software suite, such as computer-assisted coding, CDI, and abstracting and physician query; and eValuator, a cloud-based pre- and post-bill coding analysis platform. In addition, it provides financial management solutions, including accounts receivable management, denials management, claims processing, spend management, and audit management; patient care solutions; and custom integration, training, electronic image conversion, audit, and database monitoring services. The company sells its solutions and services through direct sales force and reseller partnerships. Streamline Health Solutions, Inc. was founded in 1989 and is headquartered in Alpharetta, Georgia.
Most Popular Stories View All
STRM Latest News Stream
|Loading, please wait...|
STRM Latest Social Stream
View Full STRM Social Stream
Latest STRM News From Around the Web
Below are the latest news stories about STREAMLINE HEALTH SOLUTIONS INC that investors may wish to consider to help them evaluate STRM as an investment opportunity.
New Jersey Health System Adds Streamline Health® eValuator™
Acquires Automated Pre-Bill Coding Analysis for Inpatient and Outpatient Care Atlanta, GA, March 06, 2023 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (NASDAQ: STRM), a leading provider of solutions that enable healthcare providers to proactively improve financial performance, announced today it has signed a contract with a 1,600-bed health system in New Jersey. The organization will use eValuator’s automated pre-bill coding analysis platform to help improve revenue integrity and financ
Should You Think About Buying Streamline Health Solutions, Inc. (NASDAQ:STRM) Now?
While Streamline Health Solutions, Inc. ( NASDAQ:STRM ) might not be the most widely known stock at the moment, it led...
Streamline Health® Announces Preliminary Fiscal Year 2022 Revenue and Booked SaaS ACV
Atlanta, GA, Feb. 15, 2023 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (“Streamline” or the “Company”) (Nasdaq: STRM), a leading provider of solutions that enable healthcare providers to proactively address revenue leakage and improve financial performance, today announced preliminary revenue and booked SaaS ACV results for the fiscal year ended January 31, 2023. The Company acquired Avelead Consulting, LLC (“Avelead”) on August 16, 2021, and all GAAP operating results attributable to
Is There An Opportunity With Streamline Health Solutions, Inc.'s (NASDAQ:STRM) 31% Undervaluation?
Does the January share price for Streamline Health Solutions, Inc. ( NASDAQ:STRM ) reflect what it's really worth...
Streamline Health® Partner Signs New Contract to Utilize RevID™ at California-Based Medical Center
Leveraging RevID’s Automated Charge Reconciliation for Improved Financial Performance Atlanta, GA, Jan. 26, 2023 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (NASDAQ: STRM), a leading provider of solutions that enable healthcare providers to proactively address revenue leakage and improve financial performance, announced today it has signed a contract with a partner for the use of RevID at a 350-bed medical center based in California. Through its automated charge reconciliation, RevID w
STRM Price Returns
Continue Researching STRMWant to see what other sources are saying about Streamline Health Solutions Inc's financials and stock price? Try the links below:
Streamline Health Solutions Inc (STRM) Stock Price | Nasdaq
Streamline Health Solutions Inc (STRM) Stock Quote, History and News - Yahoo Finance
Streamline Health Solutions Inc (STRM) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...